The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial.
about
Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled TrialsReview of Neuro-nutrition Used as Anti-Alzheimer Plant, Spinach, Spinacia oleracea.Pharmacological aspects of galantamine for the treatment of Alzheimer's disease.Dementia risk and prevention by targeting modifiable vascular risk factors.Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.
P2860
The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The effect of galantamine on b ...... a randomized controlled trial.
@ast
The effect of galantamine on b ...... a randomized controlled trial.
@en
type
label
The effect of galantamine on b ...... a randomized controlled trial.
@ast
The effect of galantamine on b ...... a randomized controlled trial.
@en
prefLabel
The effect of galantamine on b ...... a randomized controlled trial.
@ast
The effect of galantamine on b ...... a randomized controlled trial.
@en
P2093
P2860
P50
P356
P1476
The effect of galantamine on b ...... a randomized controlled trial.
@en
P2093
Dirk L Knol
H Robert Brashear
Jeffrey S Nye
Niels D Prins
P2860
P2888
P356
10.1186/ALZRT275
P407
P577
2014-07-21T00:00:00Z
P5875
P6179
1030131341